ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Jakavi 15 mg, Tabletten - 3 x 56 Tablette(n)
62126005 PPNovartis Pharma Schweiz AG
Jakavi 15 mg, Tabletten27.12.2012
  27.12.2012
Ruxolitinib (L01EJ01) 
WHO-DDD 
07.16.10.3 x 56 Tablette(n)
07.16.10. 
A  
No 
IPCI
PR  
k.A.PR
  
7680621260057Synthetika
  
Composition
ruxolitinibum 15 mg ut ruxolitinibi phosphas, lactosum monohydricum 214.35 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hydroxypropylcellulosum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.97 mg.
Packungsbestandteile
Tablets 
 
Active AgentDose
Ruxolitinibum15 mg
BAG: Active AgentDose
Ruxolitinibum15 mg
 
Inactive agentsDose
Carboxymethylamylum Natricum A 
Cellulosum Microcristallinum 
Hydroxypropylcellulosum 
Lactose Monohydrate214.35 mg
Magnesii Stearas 
Povidonum K30
Pro Compresso 
Silica Colloidalis Anhydrica 
 
Source
Data was imported : 05.08.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home